Organon (NYSE: OGN) reported Q1 EPS of $1.02, $0.11 better than the analyst estimate of $0.91. Revenue for the quarter came in at $1.51 billion versus the consensus estimate of $1.55 billion.

GUIDANCE:

Organon sees FY2025 revenue of $6.125-6.325 billion, versus the consensus of $6.292 billion.

For earnings history and earnings-related data on Organon (OGN) click here.